Taiwan Land Development Corp (TLDC, 台灣土地開發) has partnered with Ivy Life Sciences Co (常春藤生命科學) to develp an immunotherapy business in Kinmen, with a view to attracting customers from China.
The Taipei-based developer inked a memorandum of understanding with Ivy Life to set up a cell biology laboratory on the outlying island, which could start operating in 2021 after gaining approval from heath authorities.
The joint venture, valued at NT$500 million (US$15.89 million), came after the government in September last year gave its go-ahead to special rules governing immunotherapy, a type of cancer treatment that boosts the body’s natural defenses to fight cancer.
Photo: Chen Yung-chi, Taipei Times
The Ministry of Health and Welfare on May 3 issued the first cell treatment license to Tri-Service General Hospital, allowing it to use cell-based immunotherapy with cytokine induced-killer cells (CIK) on patients, with help from Ivy Life, the only government-certified laboratory with the domain knowhow.
The deregulation makes Taiwan the first nation in Asia to tap into a business linked to cell treatment that could generate NT$10 billion in the next six months alone, Ivy Life general manager Terry Chang (張泰銘) said.
The treatment targets mainly wealthy patients with advanced lung, liver or blood cancer, as well as degenerative arthritis, cartilage defects and other illnesses, Chang said.
TLDC runs a shopping mall, Wind Lion Plaza (風獅城), in Kinmen that has become a popular attraction among Chinese tourists, TLDC chairman Chiu Fu-sheng (邱復生) said.
Kinmen is only 40 minutes from Xiamen, China, by boat.
Rich Chinese patients might desire the treatment, which can help strengthen the immune system without negative side effects, but is not yet available in China, Chang said.
A treatment course would need six to eight shots at a cost of NT$300,000 each, he said.
The laboratory would be set up in a residential complex, another part of a build-operate-transfer venture with the county government like the shopping mall, TLDC president Vicki Chiu (邱于芸) said.
Kinmen is ideal for developing tourism and preventive medicine given its scenic views and a fast-growing number of senior citizens, Viki Chiu said, as the offshore county has lost its young population to Taiwan proper.
The cell treatment could bring more tourists to Kinmen and invigorate its economy as a whole, Chiu said.
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s biggest contract chipmaker, booked its first-ever profit from its Arizona subsidiary in the first half of this year, four years after operations began, a company financial statement showed. Wholly owned by TSMC, the Arizona unit contributed NT$4.52 billion (US$150.1 million) in net profit, compared with a loss of NT$4.34 billion a year earlier, the statement showed. The company attributed the turnaround to strong market demand and high factory utilization. The Arizona unit counts Apple Inc, Nvidia Corp and Advanced Micro Devices Inc among its major customers. The firm’s first fab in Arizona began high-volume production
VOTE OF CONFIDENCE: The Japanese company is adding Intel to an investment portfolio that includes artificial intelligence linchpins Nvidia Corp and TSMC Softbank Group Corp agreed to buy US$2 billion of Intel Corp stock, a surprise deal to shore up a struggling US name while boosting its own chip ambitions. The Japanese company, which is adding Intel to an investment portfolio that includes artificial intelligence (AI) linchpins Nvidia Corp and Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), is to pay US$23 a share — a small discount to Intel’s last close. Shares of the US chipmaker, which would issue new stock to Softbank, surged more than 5 percent in after-hours trading. Softbank’s stock fell as much as 5.4 percent on Tuesday in Tokyo, its
COLLABORATION: Softbank would supply manufacturing gear to the factory, and a joint venture would make AI data center equipment, Young Liu said Hon Hai Precision Industry Co (鴻海精密) would operate a US factory owned by Softbank Group Corp, setting up what is in the running to be the first manufacturing site in the Japanese company’s US$500 billion Stargate venture with OpenAI and Oracle Corp. Softbank is acquiring Hon Hai’s electric-vehicle plant in Ohio, but the Taiwanese company would continue to run the complex after turning it into an artificial intelligence (AI) server production plant, Hon Hai chairman Young Liu (劉揚偉) said yesterday. Softbank would supply manufacturing gear to the factory, and a joint venture between the two companies would make AI data
The Taiwan Automation Intelligence and Robot Show, which is to be held from Wednesday to Saturday at the Taipei Nangang Exhibition Center, would showcase the latest in artificial intelligence (AI)-driven robotics and automation technologies, the organizer said yesterday. The event would highlight applications in smart manufacturing, as well as information and communications technology, the Taiwan Automation Intelligence and Robotics Association said. More than 1,000 companies are to display innovations in semiconductors, electromechanics, industrial automation and intelligent manufacturing, it said in a news release. Visitors can explore automated guided vehicles, 3D machine vision systems and AI-powered applications at the show, along
RSS